The metabolic reprogramming of T cells controls airway remodeling in severe asthma
This study identifies that metabolic reprogramming of Th17 cells via the OXPHOS pathway drives LIGHT-mediated airway remodeling in severe mixed granulocytic asthma, demonstrating that dual blockade of OXPHOS and LIGHT effectively reverses disease features and restores regulatory T cell numbers.